TY  - GEN
AU  - Howell,Anthony
AU  - Bergh,Jonas
TI  - Insights into the place of fulvestrant for the treatment of advanced endocrine responsive breast cancer
SN  - 1527-7755
PY  - 2010///1108
KW  - Antineoplastic Agents, Hormonal
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - chemistry
KW  - Clinical Trials, Phase III as Topic
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Estradiol
KW  - Estrogen Antagonists
KW  - Female
KW  - Fulvestrant
KW  - Humans
KW  - Injections, Intramuscular
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Postmenopause
KW  - Quality of Life
KW  - Randomized Controlled Trials as Topic
KW  - Receptors, Estrogen
KW  - analysis
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Editorial; Comment
UR  - https://doi.org/10.1200/JCO.2010.30.6266
ER  -